Pac modulated the expression of PPARα (Peroxisome proliferator-activated receptor α), MAPKs (Mitogen-activated protein kinases), and ferroptosis pathways, thereby ameliorating MASLD. Here, PPARA is linked to metabolic dysfunction-associated steatotic liver disease.